Literature DB >> 10051297

Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.

K A Glatter1, J Cheng, P Dorostkar, G Modin, S Talwar, M Al-Nimri, R J Lee, L A Saxon, M D Lesh, M M Scheinman.   

Abstract

BACKGROUND: We correlated the electrophysiologic (EP) effects of adenosine with tachycardia mechanisms in patients with supraventricular tachycardias (SVT). METHODS AND
RESULTS: Adenosine was administered to 229 patients with SVTs during EP study: atrioventricular (AV) reentry (AVRT; n=59), typical atrioventricular node reentry (AVNRT; n=82), atypical AVNRT (n=13), permanent junctional reciprocating tachycardia (PJRT; n=12), atrial tachycardia (AT; n=53), and inappropriate sinus tachycardia (IST; n=10). There was no difference in incidence of tachycardia termination at the AV node in AVRT (85%) versus AVNRT (86%) after adenosine, but patients with AVRT showed increases in the ventriculoatrial (VA) intervals (13%) compared with typical AVNRT (0%), P<0.005. Changes in atrial, AV, or VA intervals after adenosine did not predict the mode of termination of long R-P tachycardias. For patients with AT, there was no correlation with location of the atrial focus and adenosine response. AV block after adenosine was only observed in AT patients (27%) or IST (30%). Patients with IST showed atrial cycle length increases after adenosine (P<0.05) with little change in activation sequence. The incidence of atrial fibrillation after adenosine was higher for those with AVRT (15%) compared with typical AVNRT (0%) P<0.001, or atypical AVNRT (0%) but similar to those with AT (11%) and PJRT (17%).
CONCLUSIONS: The EP response to adenosine proved of limited value to identify the location of AT or SVT mechanisms. Features favoring AT were the presence of AV block or marked shortening of atrial cycle length before tachycardia suppression. Atrial fibrillation was more common after adenosine in patients with AVRT, PJRT, or AT. Patients with IST showed increases in cycle length with little change in atrial activation sequence after adenosine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051297     DOI: 10.1161/01.cir.99.8.1034

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  The use of adenosine to identify dormant conduction after accessory pathway ablation: a single center experience and literature review.

Authors:  Vagner Pegoraro; Beatriz Paiva; Ahmed AlTurki; Michelle Samuel; Riccardo Proietti; Vidal Essebag; Martin L Bernier
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

4.  Atrial fibrillation during adenosine pharmacologic stress testing.

Authors:  Matthew Cummings; Jaffar Raza; Assad Movahed
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

5.  FBI: fast broad and irregular tachycardia.

Authors:  M Kofflard; R van Mechelen
Journal:  Neth Heart J       Date:  2006-02       Impact factor: 2.380

6.  Adenosine-induced tachycardia acceleration: an unusual proarrhythmia.

Authors:  Vini Singh; Negar Salehi; Ranjan Kumar Thakur
Journal:  BMJ Case Rep       Date:  2015-01-27

7.  Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia.

Authors:  James Michael Bensler; Christopher M Frank; Mehdi Razavi; Abdi Rasekh; Mohammad Saeed; Phillip C Haas; Alireza Nazeri; Ali Massumi
Journal:  Tex Heart Inst J       Date:  2010

8.  Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

Authors:  Demosthenes G Katritsis; Giuseppe Boriani; Francisco G Cosio; Pierre Jais; Gerhard Hindricks; Mark E Josephson; Roberto Keegan; Bradley P Knight; Karl-Heinz Kuck; Deirdre A Lane; Gregory Yh Lip; Helena Malmborg; Hakan Oral; Carlo Pappone; Sakis Themistoclakis; Kathryn A Wood; Kim Young-Hoon; Carina Blomström Lundqvist
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 9.  Drug-induced atrial fibrillation.

Authors:  Yaman Kaakeh; Brian R Overholser; John C Lopshire; James E Tisdale
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

10.  To decide medical therapy according to ECG criteria in patients with supraventricular tachycardia in emergency department: adenosine or diltiazem.

Authors:  Halil Dogan; Dogac Niyazi Ozucelik; Kurtulus Aciksari; Ilker Murat Caglar; Nursel Okutan; Mustafa Yazicioglu; Baris Murat Avyaci; Cem Simsek; Derya Ozasir; Tufan Akin Giray; Cem Ayan; Feridun Celikmen; Yıldız Okuturlar; Sezgin Sarikaya
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.